FDC
Back to Balance Sheet
|
FDC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FDC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of FDC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 32.90 | |
| Mar2024 | ₹17 Cr | 55.45 | |
| Mar2023 | ₹11 Cr | -31.06 | |
| Mar2022 | ₹16 Cr | 47.83 | |
| Mar2021 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,936.1 Cr | -1% | 11.9% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1% |
11.9% |
-11.8% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses